Overview
- Editors:
-
-
Nabil F. Saba
-
Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, USA
-
Bassel F. El-Rayes
-
Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, USA
- Describes current approaches to staging, diagnosis, prognostic evaluation, and management of esophageal cancer
- Offers detailed guidance on multidisciplinary management of early-stage disease Considers the role of chemoprevention
- Discusses the treatment of metastatic and recurrent disease
Access this book
Other ways to access
Table of contents (14 chapters)
-
-
- Juliana Andrici, Guy D. Eslick
Pages 1-23
-
-
- Brian S. Robinson, N. Volkan Adsay, Alyssa M. Krasinskas
Pages 41-60
-
- Adam Templeton, Andrew Kaz, William M. Grady
Pages 61-82
-
- Oliver J. Old, L. Max Almond, Hugh Barr, Janusz Jankowski
Pages 83-91
-
-
- A. Tuba Karagulle Kendi, Valeria M. Moncayo, David M. Schuster
Pages 105-121
-
- Michelle P. Clermont, Anthony M. Gamboa, Field F. Willingham
Pages 123-148
-
-
- Mark Stavas, A. Bapsi Chakravarthy
Pages 157-172
-
- Joseph K. Salama, Manisha Palta, Jordan A. Torok
Pages 173-185
-
- Justin C. Voog, Theodore S. Hong
Pages 187-201
-
- Geoffrey Y. Ku, David H. Ilson
Pages 203-220
-
- Sameh Mikhail, Tanios Bekaii-Saab
Pages 221-244
About this book
​This book reviews the recent progress made in the prevention, diagnosis, and treatment of esophageal cancer. Epidemiology, molecular biology, pathology, staging, and prognosis are first discussed. The radiologic assessment of esophageal cancer and the role of endoscopy in diagnosis, staging, and management are then described. The principles of surgical resection, radiation therapy, and systemic chemotherapy for esophageal cancer are explained, and particular attention is paid to the multidisciplinary management of early-stage cervical, thoracic, distal, and junctional tumors. Up-to-date information is also provided on the treatment of metastatic and recurrent disease and on approaches that may affect future care, such as chemoprevention. Esophageal cancer remains one of the least studied cancers although it accounts for more than 400,000 deaths across the globe each year. The majority of esophageal cancers worldwide are squamous cell carcinomas, yet in the past few decades major epidemiologic changes have occurred affecting the incidence of adenocarcinomas in Western countries. Despite the advances in surgical and non-surgical therapies, overall survival has not changed significantly. It is hoped that Esophageal Cancer: Prevention, Diagnosis and Therapy will assist specialists from a variety of disciplines, including surgery, radiation therapy, gastroenterology, and medical oncology, in delivering optimal, up-to-date care to the benefit of patients.
